Thermo Fisher partners EDB for US$130m sterile fill-and-finish facility
Add BT as a preferred source
Singapore
THERMO Fisher Scientific's plans to build a new US$130 million sterile fill-and-finish facility in Singapore, with the support of the Singapore Economic Development Board (EDB), will create some 300 jobs once operational in 2022.
The investment is an "important addition to the manufacturing capacity needed by global pharmaceutical and vaccine companies in the ongoing fight against Covid-19," EDB chairman Beh Swan Gin said in a press release late last week.
TRENDING NOW
‘I felt like dying’: Thai Singha beer scion speaks up after disclosure of alleged sexual abuse
CDL, Hong Realty outbid 3 other bidders with S$542.4 million offer at S$1,865 psf ppr for Peck Hay plot
Private equity giant Carlyle can grow bigger but needs to stay on its toes: co-founder David Rubenstein
Evergrande’s liquidation prompts some PwC partners to shield assets, contemplate divorce
